Partner Investment Management
Latest statistics and disclosures from Partner Investment Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Audentes Therapeutics, Alexion Pharmaceuticals, Allena Pharmaceuticals, GILD, PEN, and represent 29.21% of Partner Investment Management's stock portfolio.
- Added to shares of these 10 stocks: BIIB, ELV, HUM, CNC, PFE, ICUI, UNH, Immunomedics, ABT, MPSYF.
- Started 14 new stock positions in Immunomedics, Amarin Corporation, PFE, UNH, ABT, HUM, HALO, ICUI, CNC, BIIB. ELV, VRTX, MPSYF, ABBV.
- Reduced shares in these 10 stocks: Novo-nordisk A/s Sedol# 707752 (-$6.2M), , MCHP, ZBH, BMRN, TWLO, WDC, INTU, , Alexion Pharmaceuticals.
- Sold out of its positions in Acorda Therap note 1.75% 6/15, AMD, BABA, AMK, AVRO, Coupa Software, Dermira Inc note 3.000% 5/1, DXCM, Eidos Therapeutics, EQ.
- Partner Investment Management was a net seller of stock by $-48M.
- Partner Investment Management has $14M in assets under management (AUM), dropping by -76.15%.
- Central Index Key (CIK): 0001442276
Tip: Access up to 7 years of quarterly data
Positions held by Partner Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Partner Investment Management
Partner Investment Management holds 41 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Audentes Therapeutics | 7.7 | $1.1M | -29% | 18k | 59.85 |
|
| Alexion Pharmaceuticals | 6.5 | $911k | -61% | 8.4k | 108.18 |
|
| Allena Pharmaceuticals | 5.6 | $776k | 284k | 2.73 |
|
|
| Gilead Sciences (GILD) | 5.1 | $708k | -61% | 11k | 64.97 |
|
| Penumbra (PEN) | 4.4 | $608k | -70% | 3.7k | 164.37 |
|
| Zimmer Holdings (ZBH) | 4.0 | $552k | -79% | 3.7k | 149.63 |
|
| Biogen Idec (BIIB) | 3.9 | $546k | NEW | 1.8k | 296.90 |
|
| Nevro (NVRO) | 3.8 | $531k | -21% | 4.5k | 117.61 |
|
| Anthem (ELV) | 3.6 | $504k | NEW | 1.7k | 301.98 |
|
| Humana (HUM) | 3.5 | $494k | NEW | 1.3k | 366.74 |
|
| Iqvia Holdings (IQV) | 3.2 | $452k | -65% | 2.9k | 154.48 |
|
| Cigna Corp (CI) | 3.2 | $453k | -68% | 2.2k | 204.42 |
|
| BioMarin Pharmaceutical (BMRN) | 3.2 | $451k | -81% | 5.3k | 84.63 |
|
| Aerie Pharmaceuticals | 3.1 | $436k | +7% | 18k | 24.18 |
|
| Allergan | 3.1 | $436k | -69% | 2.3k | 191.06 |
|
| Centene Corporation (CNC) | 3.1 | $430k | NEW | 6.8k | 62.88 |
|
| Arena Pharmaceuticals | 3.1 | $431k | -67% | 9.5k | 45.44 |
|
| Novartis (NVS) | 2.8 | $392k | -60% | 4.3k | 91.80 |
|
| Hca Holdings (HCA) | 2.5 | $345k | -68% | 2.3k | 147.75 |
|
| Pfizer (PFE) | 2.1 | $294k | NEW | 7.5k | 39.24 |
|
| ICU Medical, Incorporated (ICUI) | 1.9 | $258k | NEW | 1.4k | 186.82 |
|
| Dermira | 1.8 | $256k | -43% | 17k | 15.16 |
|
| Icon (ICLR) | 1.7 | $241k | -56% | 1.4k | 171.90 |
|
| UnitedHealth (UNH) | 1.7 | $233k | NEW | 791.00 | 294.56 |
|
| Irhythm Technologies (IRTC) | 1.7 | $231k | -73% | 3.4k | 68.16 |
|
| Immunomedics | 1.6 | $230k | NEW | 11k | 21.14 |
|
| Abbott Laboratories (ABT) | 1.6 | $223k | NEW | 2.6k | 86.94 |
|
| Molina Healthcare (MOH) | 1.4 | $188k | -80% | 1.4k | 135.54 |
|
| Edwards Lifesciences (EW) | 1.3 | $184k | -78% | 788.00 | 233.50 |
|
| D Fluidigm Corp Del (LAB) | 0.9 | $132k | +7% | 38k | 3.49 |
|
| Morphosys (MPSYF) | 0.9 | $126k | NEW | 994.00 | 126.76 |
|
| Catalent | 0.9 | $126k | -83% | 2.2k | 56.48 |
|
| Abbvie (ABBV) | 0.8 | $112k | NEW | 1.3k | 88.26 |
|
| Axonics Modulation Technolog (AXNX) | 0.8 | $110k | +105% | 4.0k | 27.65 |
|
| Cardiovascular Systems | 0.7 | $96k | -66% | 2.0k | 48.36 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.7 | $95k | NEW | 434.00 | 218.89 |
|
| Halozyme Therapeutics (HALO) | 0.6 | $82k | NEW | 4.7k | 17.63 |
|
| Amarin Corporation | 0.6 | $81k | NEW | 3.8k | 21.56 |
|
| Coherus Biosciences (CHRS) | 0.5 | $68k | -51% | 3.8k | 18.03 |
|
| Acorda Therapeutics | 0.3 | $37k | -7% | 18k | 2.02 |
|
| Endologix | 0.0 | $4.0k | -15% | 2.4k | 1.64 |
|
Past Filings by Partner Investment Management
SEC 13F filings are viewable for Partner Investment Management going back to 2010
- Partner Investment Management 2019 Q4 filed Feb. 14, 2020
- Partner Investment Management 2019 Q3 filed Nov. 14, 2019
- Partner Investment Management 2019 Q2 filed Aug. 14, 2019
- Partner Investment Management 2019 Q1 filed May 15, 2019
- Partner Investment Management 2018 Q4 filed Feb. 14, 2019
- Partner Investment Management 2018 Q3 filed Nov. 13, 2018
- Partner Investment Management 2018 Q2 filed Aug. 14, 2018
- Partner Investment Management 2018 Q1 filed May 15, 2018
- Partner Investment Management 2017 Q4 filed Feb. 14, 2018
- Partner Investment Management 2017 Q3 filed Nov. 14, 2017
- Partner Investment Management 2017 Q2 filed Aug. 14, 2017
- Partner Investment Management 2017 Q1 filed May 15, 2017
- Partner Investment Management 2016 Q4 filed Feb. 14, 2017
- Partner Investment Management 2016 Q3 filed Nov. 14, 2016
- Partner Investment Management 2016 Q2 filed Aug. 15, 2016
- Partner Investment Management 2016 Q1 filed May 16, 2016